BeiGene
BGNE
#910
Rank
โ‚ฌ20.91 B
Marketcap
185,73ย โ‚ฌ
Share price
0.15%
Change (1 day)
9.65%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company